These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22457621)

  • 21. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
    Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
    J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV.
    Serra-Moreno R; Jia B; Breed M; Alvarez X; Evans DT
    Cell Host Microbe; 2011 Jan; 9(1):46-57. PubMed ID: 21238946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SERINC5 Potently Restricts Retrovirus Infection
    Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
    McNatt MW; Zang T; Hatziioannou T; Bartlett M; Fofana IB; Johnson WE; Neil SJ; Bieniasz PD
    PLoS Pathog; 2009 Feb; 5(2):e1000300. PubMed ID: 19214216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
    Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
    PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
    Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
    J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
    Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
    J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
    Miyakawa K; Ryo A; Murakami T; Ohba K; Yamaoka S; Fukuda M; Guatelli J; Yamamoto N
    PLoS Pathog; 2009 Dec; 5(12):e1000700. PubMed ID: 20019814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice.
    Treger RS; Tokuyama M; Dong H; Salas-Briceno K; Ross SR; Kong Y; Iwasaki A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
    Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
    J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of Tetherin Inhibition of Alphavirus Release.
    Wan JJ; Ooi YS; Kielian M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins.
    Liu Y; Luo S; He S; Zhang M; Wang P; Li C; Huang W; Hu B; Griffin GE; Shattock RJ; Hu Q
    Virology; 2015 Jan; 475():96-109. PubMed ID: 25462350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
    Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
    Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of budding/release of porcine endogenous retrovirus.
    Abe M; Fukuma A; Yoshikawa R; Miyazawa T; Yasuda J
    Microbiol Immunol; 2014 Aug; 58(8):432-8. PubMed ID: 24931347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Lassa and Marburg virus production by tetherin.
    Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
    J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of porcine endogenous retrovirus release by porcine and human tetherins.
    Mattiuzzo G; Ivol S; Takeuchi Y
    J Virol; 2010 Mar; 84(5):2618-22. PubMed ID: 20015985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.
    Schindler M; Rajan D; Banning C; Wimmer P; Koppensteiner H; Iwanski A; Specht A; Sauter D; Dobner T; Kirchhoff F
    Retrovirology; 2010 Jan; 7():1. PubMed ID: 20078884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.
    Londrigan SL; Tate MD; Job ER; Moffat JM; Wakim LM; Gonelli CA; Purcell DF; Brooks AG; Villadangos JA; Reading PC; Mintern JD
    PLoS One; 2015; 10(11):e0142925. PubMed ID: 26566124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetherin: holding on and letting go.
    Sauter D; Specht A; Kirchhoff F
    Cell; 2010 Apr; 141(3):392-8. PubMed ID: 20434978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.